| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6246396 | Transplantation Proceedings | 2016 | 4 Pages |
Abstract
Proteinuria, poor graft function, and primary glomerulonephritis were associated with cessation of mTORi treatment. Earlier identification of these risk factors may prevent further adverse events and optimize transplantation outcomes after mTORi conversion.
Related Topics
Health Sciences
Medicine and Dentistry
Surgery
Authors
L.M. Lim, L.F. Kung, M.C. Kuo, H.T. Kuo,